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New recommendations to reduce unnecessary blood
tests after robot-assisted radical prostatectomy
Radical prostatectomy (RP) is a standard treatment for men
with localised prostate cancer. Robot-assisted RP (RARP) is
associated with fewer intraoperative adverse events, reduced
blood loss and lower complication rates compared to open
and laparoscopic RP but delivers comparable oncological and
functional outcomes [1]. Furthermore, the use of Enhanced
Recovery after Surgery (ERAS) pathways for RARP, have
improved patient recovery and experience, reducing costs and
maintaining patient safety [2].
Despite the increased use of RARP and adoption of ERAS
pathways, the historical practice of routine postoperative
blood tests (POBT) remains common. No national or
international guidelines exist to aid clinicians to decide
whether a patient requires POBT after RARP.
The aim of our present study was to evaluate the safety value
of omitting routine POBT after RARP, and to propose
recommendations to rationalise their use in clinical practice.
The study followed established ‘Plan, Do, Study, Act’ (PDSA)
quality improvement methodology [3]. The study aims were
defined as above and outcomes were defined as below
(‘Plan’). Baseline data were collected from a retrospective
review (‘Do’) and analysed according to the plan (‘Study’).
New recommendations were created based on the
retrospective review and prospectively assessed (‘Act’).
Routine prospectively collected perioperative data were
retrospectively aggregated from 1040 consecutive patients who
underwent RARP with ERAS from 2017 to 2019 in two high-
volume tertiary centres in the UK. Data collected included:
preoperative patient demographics (age, body mass index
[BMI], American Society of Anesthesiologists [ASA] and
Charlson CoMorbidity Index [CCI] score), intraoperative data
(operative time, estimated blood loss [EBL], blood transfusion,
nerve sparing, pelvic lymph node dissection [PLND], and
complications), and postoperative data (clinical signs and
symptoms, length of stay [LOS], transfusion, and 30-day
Clavien–Dindo complications). Subjective intraoperative
difficulties, such as difficult dissection and difficult anastomosis,
were not regarded as complications. In addition, data related to
the timing of discharge and ordering, taking, analysing, and
reporting of POBT were collected. All patients had a minimum
of 30-days of follow-up. From the retrospective review, 72% of
patients were found to have no pre-, intra- or postoperative
clinical concerns but still had routine POBT; no patients in this
cohort developed a complication.
The study team, composed of experienced, high-volume
consultant robotic surgeons at both tertiary centres, reviewed
the outcomes from the retrospective data. Expert opinion was
used to recommend the following criteria for POBT:
• All patients admitted to high-dependency units (HDUs)
postoperatively.
• Patients with intraoperative concerns such as difficult
dissection or adhesions, EBL >750 mL, urine leak, bowel,
bladder or port-site injury, known coagulopathy and
salvage procedures.
• Patients with postoperative concerns such as cardiovascular
dysfunction, raised NHS England National Early Warning
Score (NEWS) or pyrexia, increasing abdominal pain,
tenderness or guarding, nausea or vomiting, high drain
output, low urine output or haematuria and wound
concern.
Detailed pre-, intra- and postoperative parameters are
presented in Table 1. A total of 1040 patients were used to
help construct the recommendations and 300 patients were
used to assess the new recommendations. Thus, 1340 patients
were included in total. The median (interquartile range
[IQR]) follow-up was 90 (78-98) days.
Across the study population, the median age was 63 years,
BMI was 28 kg/m2 and the ASA score was 2. In all, 345
(26%) patients had a CCI score of ≥1, with diabetes being the
most common comorbidity in 15% of patients. There were no
statistically significant differences between the two datasets
for preoperative characteristics. As per European Association
of Urology (EAU) intraoperative adverse incident
classification, there were two Grade II events (two bowel
repairs), four Grade III events (three bowel repairs and one
vascular injury), and no Grade ≥IV events. Clinical concerns,
defined as suspicion raised by the clinical team as per the
recommendations, were reported in 221 (16%) patients, the
most common concern was increasing abdominal pain in 75
patients (6%).
The overall postoperative 30-day Clavien–Dindo complication
rate was 5%. The most common complication was a
haematoma, occurring in 21 (2%) patients. A total of 3% of
patients went to HDU due to premorbid or intraoperative
concerns and 4% had an intraoperative concern flagged by
the operating surgeon. In 16% clinical concerns were raised
by the surgical team postoperatively. The perioperative
transfusion rate was 0.9% (nine patients) and median LOS
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was 1 day. No patients died within the short 30-day follow-
up period.
Implementation of the recommendations resulted in a
decrease of POBT requested from 100% to 27% (P = 0.001).
The new recommendations were associated with a reduction
in POBT related discharge delays from 6% to 0% (P = 0.008).
No complications were missed, and one patient had an
unplanned re-admission within 90-days for urinary sepsis.
Postoperative blood tests should be used to assess variation in
haematological or biochemical parameters after surgery where
variation is likely to occur and when it is likely to reflect
adverse events [4]. The results of our present study show that
routine POBT in patients with no adverse clinical findings do
not reveal any complications that are not suspected by
clinical judgement. POBT alone without clinical assessment,
would only be useful in helping to diagnose 43% of all
complications. Intra- and postoperative clinical assessment
Table 1 Pre-, intra- and postoperative variables.
Variable Total Derivation dataset Validation dataset P
N 1340 1040 300
Preoperative
Age, years, median (IQR) 63 (61–65) 63 (61–65) 63 (60–66) 0.364
BMI, kg/m2, median (IQR) 28 (27–29) 28 (27–30) 28 (27–31) 0.462
ASA score, median 2 2 2 0.98
CCI score ≥1, n (%) 345 (26) 283 (27) 62 (23) 0.31
Intraoperative
Operation time, min, median (IQR) 120 (100–140) 120 (100–150) 120 (90–150) 0.126
EBL, mL, median (IQR) 250 (200–300) 250 (200–300) 260 (180–350) 0.371
Transfusion, n (%) 3 (0.2) 3 (0.3) 0 (0) 1
Nerve sparing, n (%)
Nil 253 (19) 178 (17) 75 (25) 0.515
Unilateral 543 (41) 432 (42) 111 (37)
Bilateral 543 (41) 429 (41) 114 (38)
PLND, n (%) 467 (35) 374 (36) 93 (31) 0.236
Concerns and complications, n (%) 51 (4) 36 (3) 15 (5) 0.762
EBL >750 mL 29 (2) 21 (2) 7 (2)
Anastomotic leak 11 (1) 6 (0.6) 5 (2)
Bowel injury 6 (0.4) 5 (0.5) 1 (0.3)
Vascular injury 3 (0.2) 2 (0.2) 1 (0.3)
Bladder injury 2 (0.1) 1 (0.1) 1 (0.3)
Port-site injury 1 (0.1) 1 (0.1) 0 (0)
Postoperative
Clinical concerns, n (%) 221 (16) 161 (15) 60 (20) 0.25
Increasing abdominal pain 75 (6) 59 (6) 16 (5)
High drain output/leak 42 (3) 33 (3.2) 9 (3)
Cardiovascular dysfunction 39 (3) 25 (2) 14 (5)
Nausea/vomiting 26 (2) 17 (1.6) 9 (3)
Low urine output 20 (1) 15 (1) 5 (2)
Wound concern 5 (0.3) 4 (0.4) 1 (0.3)
Oxygen desaturations 5 (0.3) 4 (0.4) 1 (0.3)
Bleeding 5 (0.3) 3 (0.3) 2 (0.6)
Calf pain 1 (0.1) 1 (0.1) 0 (0)
Confusion 3 (0.2) 0 (0) 3 (1)
Transfusion, n (%) 6 (0.4) 6 (0.6) 0 (0) 1
Complications (30-day), n (%) 68 (5) 48 (5) 20 (7) 0.615
Haematoma 21 (2) 15 (1) 6 (2)
Anastomotic urine leak 9 (0.6) 7 (0.7) 2 (0.6)
UTI 11 (0.8) 6 (0.6) 5 (2)
Ileus 7 (0.5) 5 (0.5) 2 (0.6)
Bowel injury 5 (0.4) 4 (0.4) 1 (0.3)
Wound breakdown 5 (0.4) 4 (0.4) 1 (0.3)
Acute kidney injury 7 (0.5) 4 (0.4) 3 (0.9)
Renal/ureteric injury 2 (0.1) 2 (0.2) 0 (0)
Deep vein thrombosis 1 (0.1) 1 (0.1) 0 (0)
Clavien-Dindo complications, n (%) 68 (5) 48 (5) 20 (7) 0.73
Grade I–II 64 (5) 44 (4) 20 (7)
Grade III–V 4 (0.2) 4 (0.4) 0 (0)
LOS, days, median (IQR) 1 (1–2) 1 (1–2) 1 (1–2) 0.934
Discharge delays, n (%) 62 (5) 62 (6) 0 (0) 0.008*
Re-admission (90-day), n (%) 14 (1) 12 (1) 2 (0.6) 0.943
*P < 0.05.
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corroborated with postoperative complications in 99.9% of
patients. Therefore, routine POBT should not be a surrogate
for thorough clinical assessment.
In the retrospective review, 6% of patients experienced a
discharge delay of ≥1 day due to missed venepuncture, mis-
labelled, mis-resulted or delayed reporting of POBT. Ravindra
et al. [5] found in 170 patients that >90% of all blood tests
requested for Grade I–III urological procedures were available
after 11:00 hours, which resulted in delayed discharge. After
issuing local guidelines there was a 75% reduction in POBT
requested with no change to patient safety. Over 1.2 million
bed-days were lost in the NHS during 2013 due to delayed
discharges, with an associated cost of £820 million [6]. Our
recommendations may help reduce the costs associated with
discharge delays and POBT.
Our recommendations resulted in a 73% reduction in POBT
after RARP and show that procedure specific
recommendations may significantly reduce POBT requests
across a variety of surgical procedures. A review of 532
patients undergoing elective laparoscopic cholecystectomy
found that routine POBT do not predict complications but
may be of benefit in technically challenging cases [7].
Furthermore, other surgical specialities such as gynaecology
and general surgery are transitioning from open surgical
techniques to minimally invasive surgery, which has been
proven to lower EBL, transfusion and complication rates, and
reduce LOS [8]. Therefore, we would recommend that other
surgical specialities undertake an evaluation of their use of
routine POBT.
Our recommendations capture data from two high-volume
centres with experienced surgeons. Further multicentre
research is required to provide a more comprehensive picture
with specific cost analysis.
To conclude, routine POBT, without a clinical indication, are
not necessary after RARP. Intra- and postoperative clinical
judgement is highly accurate in predicting and diagnosing
complications. Our recommendations can avoid POBT in
nearly three out of four patients undergoing RARP.
Perioperative transfusion rates are extremely low and
hospitals could remove the need for two group and screen
samples. Furthermore, our recommendations may reduce
discharge delays and increase patient turnover to help the
financial, logistical and resource burden on NHS Trusts. Our
methodology and recommendations may be applicable to
other surgical procedures.
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